We Give Shareholders a Voice

Helix Acquisition Corp. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Helix Acquisition Corp. (“Helix” or the “Company”) (NASDAQ: HLXA) with MoonLake Immunotherapeutics AG. Upon the closing of the transaction, the company will be renamed “MoonLake Immunotherapeutics”, and the combined company‚Äôs common stock is expected to be listed on Nasdaq under the ticker symbol MLTX.

The Helix merger investigation concerns whether the Board of Helix has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.

To receive more information, please fill out the form.

Enter Your Details Below

This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

Review our Privacy Policy